Lee Wright, PhD

Chief Executive Officer
Email

Dr. Wright has over 17 years of pharma experience, including early stage drug development and refinement and preclinical studies. He has extensive experience in synthetic chemistry, medium and large-scale synthesis, and impurity profiling, SAR modeling, and metabolite analysis. In addition, he has CRO / management experience with PD-ADME studies, and modeling of safety / toxicology and animal efficacy.

He has contributed to the development of Roxadustat, currently in Phase III for the treatment of anemia and chronic kidney disease.

Sandra K. Weller, PhD

Chief Strategy Officer Biology
Email

Board of Trustees Distinguished Professor and Chair    2003 - present
Department of Molecular Biology and Biophysics
University of Connecticut School of Medicine, Farmington

Management of QMD research portfilio.

Dr. Weller has broad experience in molecular genetics, biochemistry and cell biology, with a focus on identifying molecular targets relevant to disease. Her considerable experience in multidisciplinary research development includes promotion of academic translational drug discovery efforts.

She has established a highly successful research group in molecular virology and virus-host interactions at the University of Connecticut School of Medicine, with 32 years of continuous research support totaling over $13 million in state, industry and federal support, and has one patent granted and over 100 peer-reviewed publications.

Her energetic style and collaborative leadership abilities have earned her international respect. She has led efforts to integrate strengths in clinical medicine, bioinformatics, molecular biology, biochemistry, biophysics, structural biology and medicinal chemistry to enable new discoveries in the clinical and basic sciences. This effort resulted in a $10 million state funded partnership between the University of Connecticut and Yale University, known as the Program in Innovative Therapeutics for CT's Health, or PITCH, which aims to translate basic science discoveries into therapeutic strategies that can be used to promote human health.  

Dennis Wright, PhD

Chief Strategy Officer - Chemistry
Email

Professor of Medicinal Chemistry
University of Connecticut, Storrs

Management of QMD research portfolio

Dr. Wright's research program lies at the interface of organic structure and biological function, and is grounded in a strong synthetic organic core that also includes many important aspects of modern medicinal chemistry, including structure-based drug design, drug disposition/metabolism, and high-throughput screening. He leads a successful research group at the UConn School of Pharmacy, with 18 years continuous research support, including over $10 million in funding, six awarded patents and over 100 peer-reviewed publications, and has trained over 20 doctoral students and several post-doctoral fellows.

Adriane Mosley

Chief Operating Officer
Email

Ms. Mosley has 18 years of experience in laboratory research and management. She previously worked as a Research Assistant and Laboratory Manager in labs focusing on cancer research, neuropharmacology, and stem cell research, working with a variety of animal models.  She joined QMD in 2018, and is responsible for administrative functions as well as animal studies.

Bradford Weller, JD

Vice President, Business Development
Email

Brad Weller is an accomplished and driven c-level executive with experience providing management and legal leadership, oversight, and guidance within technology, software, and bio-science businesses. He is a results-oriented leader with diverse and complex transactional experience. 

He is adept with managing projects and teams, international transactions, contracting, cross-border mergers and acquisitions (M&A), and employment. He has extensive corporate governance expertise, and is skilled in working with boards of directors, audit committees, and compensation committees. He has a track record of successful resolution of commercial, M&A, employment, and IP infringement/protection disputes.

Sarah King

Chief Public Relations Officer
Email

Ms. King has over 30 years of experience in communications and public relations for a wide variety of clients. As the creative director for fund raising for the American Cancer Society California division, she developed direct mail, brochures, case statement and other materials designed to communicate complex research developments to donors. As a public relations executive, she developed press releases, special events and printed materials. As a free lance marketing communications consultant, she developed content and produced printed materials and videos. She is co-founder of the Ecological Building Network, and currently serves as chief business manager. In addition, she is a custom website developer for a range of clients. She joined QMD in 2018, and her responsibilities include web site development and review of marketing materials.